Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,719 | 281 | 89.7% |
| Education | $659.36 | 24 | 10.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,110 | 40 | $0 (2024) |
| Medtronic USA, Inc. | $918.08 | 13 | $0 (2020) |
| Allergan, Inc. | $824.40 | 53 | $0 (2022) |
| ABBVIE INC. | $571.66 | 32 | $0 (2024) |
| Coloplast Corp | $423.09 | 23 | $0 (2023) |
| Medtronic, Inc. | $328.96 | 21 | $0 (2024) |
| Boston Scientific Corporation | $302.55 | 11 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $208.69 | 14 | $0 (2024) |
| UROVANT SCIENCES INC | $159.73 | 10 | $0 (2022) |
| PFIZER INC. | $158.00 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $498.25 | 26 | ABBVIE INC. ($214.80) |
| 2023 | $846.70 | 46 | AbbVie Inc. ($195.40) |
| 2022 | $717.12 | 43 | ABBVIE INC. ($161.46) |
| 2021 | $954.91 | 44 | Astellas Pharma US Inc ($223.19) |
| 2020 | $801.94 | 24 | Medtronic USA, Inc. ($416.72) |
| 2019 | $1,250 | 64 | Medtronic USA, Inc. ($272.99) |
| 2018 | $999.62 | 46 | Astellas Pharma US Inc ($352.85) |
| 2017 | $310.12 | 12 | Astellas Pharma US Inc ($170.60) |
All Payment Transactions
305 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/31/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: UROLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/27/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/13/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Biological | ||||||
| 07/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: UROLOGY | ||||||
| 07/08/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 04/29/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 04/24/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: UROLOGY | ||||||
| 04/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/11/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $30.91 | General |
| Category: Prostate cancer | ||||||
| 03/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: UROLOGY | ||||||
| 03/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/13/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $22.43 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 02/12/2024 | Boston Scientific Corporation | Advantage System (Device) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Advantage_URO | ||||||
| 02/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: UROLOGY | ||||||
| 01/18/2024 | Antares Pharma, Inc. | TLANDO (Drug), XYOSTED | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 01/09/2024 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,220 | 17,457 | $420,216 | $183,284 |
| 2022 | 18 | 2,216 | 14,757 | $404,255 | $191,062 |
| 2021 | 32 | 2,277 | 14,319 | $440,986 | $190,784 |
| 2020 | 29 | 2,002 | 11,981 | $380,750 | $147,658 |
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 58 | 12,650 | $107,950 | $61,439 | 56.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 278 | 351 | $63,250 | $27,581 | 43.6% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 58 | 91 | $54,600 | $24,151 | 44.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 300 | 379 | $43,585 | $23,597 | 54.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 48 | 56 | $25,200 | $9,436 | 37.4% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 29 | 29 | $20,445 | $7,140 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $13,420 | $6,000 | 44.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 55 | 55 | $8,010 | $4,293 | 53.6% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 29 | 29 | $10,150 | $3,977 | 39.2% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 204 | 322 | $4,991 | $2,485 | 49.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 532 | 910 | $6,370 | $1,981 | 31.1% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 27 | 27 | $6,750 | $1,884 | 27.9% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 12 | 36 | $5,400 | $1,837 | 34.0% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 114 | 174 | $2,958 | $1,436 | 48.5% |
| 87088 | Bacterial urine culture | Office | 2023 | 114 | 174 | $4,524 | $1,343 | 29.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 127 | 148 | $7,400 | $1,001 | 13.5% |
| J1335 | Injection, ertapenem sodium, 500 mg | Office | 2023 | 17 | 84 | $8,400 | $885.72 | 10.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 110 | $6,050 | $851.72 | 14.1% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 29 | 29 | $10,527 | $677.15 | 6.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 13 | $975.00 | $495.00 | 50.8% |
| J1644 | Injection, heparin sodium, per 1000 units | Office | 2023 | 13 | 1,480 | $2,960 | $247.09 | 8.3% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 11 | 11 | $660.00 | $154.81 | 23.5% |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | Office | 2023 | 15 | 17 | $255.00 | $142.80 | 56.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 141 | $2,538 | $118.35 | 4.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 24 | 24 | $2,400 | $114.97 | 4.8% |
About Dr. Paula Rookis, MD
Dr. Paula Rookis, MD is a Urology healthcare provider based in Homewood, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962467969.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paula Rookis, MD has received a total of $6,378 in payments from pharmaceutical and medical device companies, with $498.25 received in 2024. These payments were reported across 305 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($5,719).
As a Medicare-enrolled provider, Rookis has provided services to 8,715 Medicare beneficiaries, totaling 58,514 services with total Medicare billing of $712,788. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Homewood, AL
- Active Since 04/20/2006
- Last Updated 01/08/2014
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1962467969
Products in Payments
- BOTOX (Biological) $1,128
- INTERSTIM (Device) $1,077
- MYRBETRIQ (Drug) $535.37
- GEMTESA (Drug) $368.42
- Myrbetriq (Drug) $214.01
- SPEEDICATH (Device) $184.53
- INTERSTIM ICON (Device) $170.13
- BOTOX THERAPEUTIC (Biological) $143.76
- GENERAL - FEMALE SUI (Device) $140.20
- Desara (Device) $125.70
- IMVEXXY (Drug) $118.68
- TOVIAZ (Drug) $105.54
- XIAFLEX (Biological) $101.93
- KEYTRUDA (Biological) $100.01
- NOCDURNA (Drug) $85.37
- Axonics (Device) $70.78
- GENTLECATH (Device) $63.66
- TITAN (Device) $62.73
- ELIGARD (Drug) $55.69
- Axonics r-SNM System (Device) $50.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Homewood
Dr. Brian Christine, M.d, M.D
Urology — Payments: $521,154
Dr. Vincent Bivins, Md, MD
Urology — Payments: $138,864
Dr. Rupa Kitchens, Md, MD
Urology — Payments: $20,604
Alison Pickering, M.d, M.D
Urology — Payments: $17,153
Dr. Donald Bragg, M.d, M.D
Urology — Payments: $14,986
Dr. Mark Deguenther, M.d, M.D
Urology — Payments: $11,473